Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tritanrix-HepB/Hib2.5 vs Tritanrix-HepB/Hiberix in Healthy Infants
NCT01061541Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2003
- Primary completion
- Jan 2004
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Tritanrix-HepB, haemophilus influenzae type b vaccine in diphtheria, Tetanus, pertussis, hepatitis B (HBV), Haemophilus influenzae type b infection (Hib), sponsored by GSK. Started Aug 2003; status: completed.
02
Drugs
Tritanrix-HepBhaemophilus influenzae type b vaccine
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT01061541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01061541.